Clinical Trial Update: Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial studying MEDI0382 in combination with dapagliflozin and metformin in overweight/obese adults with type 2 diabetes; trial completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• MEDI0382
• metformin (metformin)

Snippet

Sponsor: MedImmune LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2020-01-13